U.S. Markets close in 2 hrs, 33 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 9,841.92 | -483.46 | -4.68% |
| NASDAQ | 1,834.31 | -113.08 | -5.81% |
| S&P 500 | 1,041.68 | -57.55 | -5.24% |
| Day Low 12:39 PM EDT | 1.87 | |
|---|---|---|
| Day High 09:30 AM EDT | 2.30 |
|
| Range | 0.43 | |
| Volume | 76,459 | |
| 30-Day Avg. Vol. | 189,000 |
|
| Difference | -59.55% | |
| Market Cap. | 70.91 M | |
| Change | -7.05 M | |
| Shares Out. | 37.13 M | |
| Percent Traded | 0.21% | |
| Revenue (LFY) | 7.55 M | |
| Earnings (TTM) | -56.39 M | |
| Next Earnings | 10/06/2008 |
|
| EPS (TTM) | -1.84 |
| 52-Wk Low 12:39 PM EDT | 1.87 | |
|---|---|---|
| 52-Wk High 10/11/07 | 16.56 |
|
| Range | 14.69 | |
| Prev. Close 10/3/08 | 2.10 | |
| Today's Open | 2.08 | |
| Change | -0.95% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.6746 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -1.00 |
ACADIA Pharmaceuticals puts genes and drugs together to fight disease. The development-stage company uses its proprietary R-SAT technology to identify and evaluate genomic targets for drug therapies, primarily ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.461 3/31/08 | -0.44 3/31/08 |
0.021
Beat
|
| Last Quarter | -0.464 6/30/08 | -0.49 6/30/08 |
-0.026
Missed
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 177,000.00 | 7.56 M |
| Gross Profit | -4.70 M | 6.49 M |
| Operating Income | -19.04 M | -62.65 M |
| Net Income | -18.29 M | -56.39 M |
